Cerivastatin
Back to searchMolecule Structure
Scientific Name
Cerivastatin
Description of the Drug
Cerivastatin is a statin (or HMG CoA reductase inhibitor) used with dietary changes to decrease lipid levels and reduce the risk of cardiovascular events.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00439
http://www.drugbank.ca/drugs/DB00439
Brand Name(s)
Lipobay
Company Owner(s)
Bayer Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16346 | ||
| PharmGKB | PA448897 | ||
| DrugBank | DB00439 | ||
| PubChem: Thomson Pharma | 14858094 | 14809054 | |
| PubChem | 446156 | ||
| LINCS | LSM-43237 | ||
| Nikkaji | J934.489F | ||
| BindingDB | 18376 | ||
| EPA CompTox Dashboard | DTXSID9022786 | ||
| DrugCentral | 577 | ||
| Brenda | 229260 | 229259 | 9778 |
| ChemicalBook | CB5115264 | ||
| Guide to Pharmacology | 2950 | ||
| rxnorm | CERIVASTATIN | CERIVASTATIN SODIUM | |
| KEGG Ligand | C07966 | ||
| ChEBI | 3558 | ||
| ZINC | ZINC000011330186 |
